CD44 and CD133 cancer stem cell markers as indicators for aggressive ovarian tumours

被引：0
|
作者：
Jovanovic, L.
Sosic-Jurjevic, B.
Cirkovic, A.
Dragicevic, S.
Filipovic, B.
Milenkovic, S.
Dugalic, S.
Gojnic-Dugalic, M.
Nikolic, A.
机构：
来源：
VIRCHOWS ARCHIV | 2024年 / 485卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
E-PS-10-05
引用
收藏
页码：S285 / S285
页数：1
相关论文
共 50 条
  • [31] CD44, CD29 and CD133 as potential markers for Cancer Stem Cells (CSC) in Head and Neck Squamous Cell Carcinoma (HNSCC)
    Perez, Aymee
    Pereira, Lutecia
    Neskey, David
    Goodwin, W.
    Slingerland, Joyce
    Franzmann, Elizabeth
    CANCER RESEARCH, 2009, 69
  • [32] Expression and Clinical Significance of Cancer Stem Cell Markers CD24, CD44, and CD133 in Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis
    Durko, L.
    Wlodarski, W.
    Stasikowska-Kanicka, O.
    Wagrowska-Danilewicz, M.
    Danilewicz, M.
    Hogendorf, P.
    Strzelczyk, J.
    Malecka-Panas, E.
    DISEASE MARKERS, 2017, 2017
  • [33] Expression of cancer stem cell markers ALDH1, CD44 and CD133 in primary tumor and lymph node metastasis of gastric cancer
    Wakamatsu, Yuta
    Sakamoto, Naoya
    Oo, Htoo Zarni
    Naito, Yutaka
    Uraoka, Naohiro
    Anami, Katsuhiro
    Sentani, Kazuhiro
    Oue, Naohide
    Yasui, Wataru
    PATHOLOGY INTERNATIONAL, 2012, 62 (02) : 112 - 119
  • [34] The prognostic value of co-expression of stemness markers CD44 and CD133 in endometrial cancer
    Jiang, Peng
    Tian, Chenfan
    Zheng, Yunfeng
    Gong, Chunxia
    Wang, Jinyu
    Liu, Ying
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [35] Clinicopathologic Significance of Putative Stem Cell Marker, CD44 and CD133, in Human Gastric Carcinoma
    Chen, Shi
    Hou, Jing-Hui
    Feng, Xing-Yu
    Zhang, Xiao-Shi
    Zhou, Zhi-Wei
    Yun, Jing-Ping
    Chen, Ying-Bo
    Cai, Mu-Yan
    JOURNAL OF SURGICAL ONCOLOGY, 2013, 107 (08) : 799 - 806
  • [36] Impact of heterogeneous nuclear ribonucleoprotein A/B subtype overexpression on the expression of cancer stem cell markers CD133 and CD44 and cellular proliferation capacity
    Wang, Meng
    Wang, Xian
    Cui, Yaping
    Wen, Xing
    CELLULAR AND MOLECULAR BIOLOGY, 2023, 69 (14) : 101 - 108
  • [37] A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers
    Lee, Yi-Jen
    Wu, Chang-Cheng
    Li, Jhy-Wei
    Ou, Chien-Chih
    Hsu, Shih-Chung
    Tseng, Hsiu-Hsueh
    Kao, Ming-Ching
    Liu, Jah-Yao
    ONCOTARGET, 2016, 7 (48) : 78499 - 78515
  • [38] Prognostic value of putative cancer stem cell markers (CD24, CD44, CD133, and ALDH1) in human papillary thyroid carcinoma
    Han, Sang-Ah
    Jang, Jae Hoon
    Won, Kyu Yeoun
    Lim, Sung-Jig
    Song, Jeong-Yoon
    PATHOLOGY RESEARCH AND PRACTICE, 2017, 213 (08) : 956 - 963
  • [39] Relationships between cancer stem cell markers (ALDH1, CD133 and CD44) and disease-free intervals in lung adenocarcinoma
    Oyama, Tsunehiro
    Uramoto, Hidetaka
    Yoneda, Kazue
    Oyama, Rintaro
    Kanayama, Masatoshi
    Shinohara, Shinji
    Takenaka, Masaru
    Kuroda, Koji
    Yamashita, Naoki
    So, Tetsuya
    Yasuda, Manabu
    Yoshimatsu, Takashi
    Hanagiri, Takeshi
    Osaki, Toshihiro
    Tanaka, Fumihiro
    Gotoh, Akinobu
    CANCER SCIENCE, 2021, 112 : 814 - 814
  • [40] CLINICOPATHOLOGICAL SIGNIFICANCE OF CD44, CD44 VARIANTS, AND CD133 EXPRESSION IN SMALL INTESTINAL ADENOCARCINOMA
    Nishimoto, Takayoshi
    Tatsuguchi, Atsushi
    Akimoto, Naohiko
    Yamada, Takeshi
    Hoshimoto, Aitoshi
    Mitsui, Keigo
    Tanaka, Shu
    Gudis, Katya
    Fujimori, Shunji
    Iwakiri, Katsuhiko
    GASTROENTEROLOGY, 2020, 158 (06) : S775 - S775
12345